SOSUM S skin care Skinject may lower the likelihood

Skinject may lower the likelihood of recurrence of certain skin cancers at the treatment site

making it suitable for a wide range of patients

Treatment Areas

It is made from hyaluronic acid

ascorbic acid injections can lead to side effects in some individuals

SOSUM S skin care Skinject may lower the likelihoodSosum S is a hyaluronic acid (HA) based dermal filler produced by JSBIO Co., Ltd., a South Korean company. It is specifically designed to address fine lines and superficial wrinkles, providing a subtle enhancement to facial features. The formulation boasts a high cross linking rate, which contributes to its effectiveness and longevity. Composition and Characteristics The primary component of Sosum S is hyaluronic acid at a concentration of 20 mg ml.